Diabetes Therapy to Improve BMI and Lung Function in CF

Key facts

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Principal Investigator

Antoinette Moran, MD

University of Minnesota

Intervention

Insulin Asparte(drug)

Enrollment

108 enrolled

Eligibility

16 years · All sexes

Timeline

2001 – 2007

Study locations (7)

• Stanford University, Palo Alto, California, United States
• Baystate Medical Center, Springfield, Massachusetts, United States
• University of Minnesota Medical Center, Minneapolis, Minnesota, United States
• Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
• Vanderbilt University Medical Center, Nashville, Tennessee, United States
• University of Utah, Salt Lake City, Utah, United States
• St. Michael's Hospital, Toronto, Ontario, Canada

Collaborators

Cystic Fibrosis Foundation · Novo Nordisk A/S

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Neonatal diabetes mellitus

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07442682
  Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
  Erasme University Hospital
• RECRUITINGNCT06407388
  Ultrasound Findings in Diabetic Pregnancies
  Eastern Virginia Medical School

See all trials for Neonatal diabetes mellitus →